Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hematologic Disease
Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
July 5th, 2007
Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), today announced that it is will provide an update on the Phase I clinical trial of AVN944 in hematologic malignancies on Tuesday, June 19, 2007, after the close of the U.S. financial markets. The Company will also host a conference call on Wednesday, June 20, 2007 at 8 a.m. Eastern Time. Interested investors, analysts, members of the media and the general public can listen to the call over the Internet from the investor section of the Company's website or by dialing the numbers listed below. A PowerPoint presentation will accompany the webcast presentation. Conference Call Details: Dial-In: (800) 291-5365(U.S.)...
Source: Blood Weekly (2007-07-05)
|
